Search Results
Jun 06, 2026, 13:55 ET Bitmine Immersion Technologies Umumkan Penetapan Harga Untuk Penawaran Saham Preferen Perpetual Seri A yang Diperbesar
sebagai joint lead bookrunner untuk penawaran ini.Penawaran ini dilakukan berdasarkan pernyataan shelf registration yang efektif pada Formulir S-3 (No. File 333-288579), yang diajukan kepada Securities and Exchange Commission ("SEC") pada tanggal 9 Juli 2025 ("Pernyataan Pendaftaran"). Penawaran
More news about: Bitmine Immersion Technologies, Inc.
Jun 06, 2026, 13:53 ET Bitmine Immersion Technologies gibt die Preisgestaltung für die aufgestockte Emission von unbefristeten Vorzugsaktien der Serie A bekannt
fungieren als gemeinsame Konsortialführer für die Emission.Das Angebot erfolgt gemäß einem wirksamen Shelf Registration Statement auf Formular S-3 (Aktenzeichen 333-288579), das am 9. Juli 2025 bei der Securities and Exchange Commission (der „SEC") eingereicht wurde (die „Registrierungserklärung").
More news about: Bitmine Immersion Technologies, Inc.
Jun 06, 2026, 13:49 ET Bitmine Immersion Technologies annonce le prix de son offre élargie d'actions privilégiées perpétuelles de série A
Cantor font office de chefs de file conjoints pour l'offre.L'offre est réalisée dans le cadre d'une déclaration d'enregistrement sur le formulaire S-3 (dossier n° 333-288579), déposée auprès de la Securities and Exchange Commission (la « SEC ») le 9 juillet 2025 (la « déclaration d'enregistrement »).
More news about: Bitmine Immersion Technologies, Inc.
Jun 06, 2026, 13:13 ET CERAVE NA PRVNÍCH CELOSVĚTOVÝCH CERAWARDS PŘIVÍTALO VÍCE NEŽ 100 OCENĚNÝCH TVŮRCŮ OBSAHU Z 22 ZEMÍ
tvůrci.Společnost CeraVe, která od svého založení v roce 2005 spolupracuje s dermatology, od samého počátku kombinuje vědecky podloženou péči o pleť s osvětou. Základem produktů jsou tři esenciální ceramidy identické s těmi, které se přirozeně vyskytují v pokožce, a hluboké odborné znalosti fungování
More news about: CeraVe
Jun 06, 2026, 13:00 ET Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions
[email protected] References Inzucchi S, Harder N, Fjelstrup S, et al. Semaglutide 2.4mg and obstructive sleep apnea in patients with overweight or obesity and cardiovascular disease: a post hoc analysis
More news about: NOVO NORDISK INC.
Jun 06, 2026, 10:41 ET Lifeline AI gewinnt das Red Bull Basement World Final, bei dem 100.000 US-Dollar als Finanzierung ohne Abgabe von Unternehmensanteilen vergeben werden
Informationen für Medien: https://www.redbullcontentpool.com/international/CP-S-20949Medienkontakt: [email protected]
More news about: Red Bull
Jun 06, 2026, 09:07 ET People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data
useful perspective on how we think about intensifying therapy for adults with type 2 diabetes who may need additional glycemic control," said Kathryn S. Tierney, MSN, APRN, FNP-BC, FAANP, Middlesex Health MultiSpecialty Group in Middletown, CT. "In practice, many patients already on semaglutide may prefer
More news about: Novo Nordisk
Jun 06, 2026, 09:01 ET People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data
useful perspective on how we think about intensifying therapy for adults with type 2 diabetes who may need additional glycemic control," said Kathryn S. Tierney, MSN, APRN, FNP-BC, FAANP, Middlesex Health MultiSpecialty Group in Middletown, CT. "In practice, many patients already on semaglutide may prefer
More news about: Novo Nordisk
Jun 06, 2026, 09:00 ET New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
https://pubmed.ncbi.nlm.nih.gov/41381175/7 Hepprich, M., Roser, P., Stiebitz, S., Felix, B., Schultes, B., Schmitz, D., Rutishauser, J., Schubert, S., Aberle, J., & Rudofsky, G. (2023). Awareness and knowledge of diabetic ketoacidosis in people with type 1 diabetes:
More news about: Abbott
Jun 06, 2026, 02:14 ET Innodisk、COMPUTEX 2026で5層構造のエッジAIエコシステムを展示
プレミスで導入できます。これを補完するAccelTuneは、Intel® Xeon® 6700シリーズプロセッサーを搭載し、NVIDIA RTX PRO GPUを2基搭載可能なAPEX-S100を用いたデモで紹介され、ノーコードでLLMをファインチューニングできる環境を提供します。これらのソリューションを組み合わせることで、企業はパブリッククラウドインフラストラクチャーに依存することなく、安全で用途に特化したLLMワークフローを構築できます。企業向けAIにとどまらず、Innodiskは、過酷な産業環境にエッジAIをどのように導入できるかを実証しています。重機向け安全ソリューション
More news about: Innodisk Corporation
Jun 05, 2026, 22:22 ET KIA ANUNCIA LOS PRECIOS DEL NUEVO SELTOS 2027
al suelo en las versiones X-Line, la capacidad aventurera del Seltos mejora aún más.El nuevo Kia Seltos del 2027 se ofrece en las versiones LX, S, EX y X-Line, y sus precios no incluyen los gastos de envío de 1495 dólares:
More news about: Kia America
Jun 05, 2026, 20:30 ET 46 Greenberg Traurig Attorneys Recognized in 2026 IAM Patent 1000
David S. Bloch: Litigation (California)
More news about: Greenberg Traurig, LLP
Jun 05, 2026, 20:30 ET Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control
drove a remarkable 69% reduction in fat mass (compared to 47% with semaglutide alone), without worsening the muscle depletion typically caused by GLP-1s.Significant Liver Health Benefits: The therapy dose-dependently reduced liver triglycerides by up to 79%, demonstrating deep resolution
More news about: Ractigen Therapeutics
Jun 05, 2026, 19:33 ET Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate
improved performance in a clinic-ready formulation and additional comparator studies will also be presented."These data are consistent with AMB-702's improved in vitro and PK profile, including superior target coverage over 24 hours, improved cell potency, flatter peak-to-trough and reduced plasma
More news about: Ambrosia Biosciences
Jun 05, 2026, 19:25 ET Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
NEW YORK, June 5, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 22, 2026, to coincide
More news about: S&P Dow Jones Indices
Jun 05, 2026, 18:57 ET Guild Wars 3, moderní, nejnovější plod žánru MMORPG, byla na Letním herním festivalu uvedena pro PC a PlayStation 5
nádherném, pulzujícím online světě, přičemž budou rozvíjet své vztahy s duchy divočiny, obyvateli Orru a ostatními hráči jako Vaelwardenů.Bojový systém, který byl od samého počátku navržen tak, aby skvěle fungoval jak s ovladačem, tak s klávesnicí, odměňuje správné umístění postavy tím, že klade důraz
More news about: NCSOFT
Jun 05, 2026, 16:50 ET S&P Global to Present at Mizuho Technology Conference 2026 on June 10, 2026
additional information presented during the session will be made available on the Company's Investor Presentations web page.About S&P GlobalS&P Global (NYSE: SPGI) enables businesses, governments, and individuals with trusted data, expertise and technology to make decisions with
More news about: S&P Global
Jun 05, 2026, 16:30 ET KB HOME OPENS RESERVE WITHIN BELLA TIERRA, A SOUGHT-AFTER MASTER PLAN IN A PRIME EAST TUCSON, ARIZONA LOCATION
Bella Tierra Reserve at a Glance:Price: From the low $300,000sLocation: East Tucson, Arizona, on East Irvington Road between South Houghton Road and South Camino Seco Home type:
More news about: KB Home
Jun 05, 2026, 15:07 ET DXC、DXC OASISを活用して北欧全域におけるIf社のテクノロジー基盤を簡素化・強化
https://mma.prnewswire.com/media/2994511/DXC_Technology_Company_DXC_to_Simplify_and_Strengthen_If_s_Techn.jpg
More news about: DXC Technology Company
Jun 05, 2026, 15:06 ET Cognizant Launches Sovereign Physical AI Platform-as-a-Service
robotics, autonomous vehicles and humanoid systems by 2033."In some ways, this is the iPhone moment for robotics and Physical AI," said Ravi Kumar S, CEO, Cognizant. "Advanced vision sensors, precise positioning, low-latency secure communication and new multimodal AI innovations are the constituents
More news about: Cognizant Technology Solutions Corporation
Jun 05, 2026, 15:04 ET Circus Circus Las Vegas ofrece la icónica diversión familiar, entretenimiento y recuerdos inolvidables de verano
cartones tienen un costo inicial de $30 por sesión.Acerca de Circus Circus Las VegasCircus Circus Las Vegas, ubicado en 2880 S Las Vegas Blvd, Las Vegas, NV 89109, es un hotel y casino de propiedad privada que cuenta con restaurantes, tiendas, entretenimiento y más de 101,000
More news about: Circus Circus
Jun 05, 2026, 15:02 ET Bitmine Immersion Technologies 宣佈計劃推出 A 系列永續優先股發售
上市。 倘上市申請獲批，BMNR 預期交易將於 A 系列優先股首次發行日期後 30 天內開始。Moelis & Company 及 Cantor 擔任是次發售的聯席主賬簿管理方。是次招股依據一份於 2025 年 7 月 9 日向美國證券交易委員會（「SEC」）提交的 S-3 表格有效貨架登記聲明（檔案編號 333-288579）（「登記聲明」）進行。 是次招股只會透過招股章程補充文件以及登記聲明中所附的招股章程進行。 初步招股章程補充文件及隨附招股章程的電子版本，可在 SEC 網站 www.sec.gov
More news about: Bitmine Immersion Technologies, Inc.
Jun 05, 2026, 14:41 ET Bitmine Immersion Technologies annuncia la proposta di offerta di azioni privilegiate perpetue di Serie A
l'offerta.L'offerta viene effettuata ai sensi di una dichiarazione di registrazione a scaffale efficace (shelf registration statement) valida sul modulo S-3 (numero di pratica 333-288579), depositata presso la Securities and Exchange Commission (la "SEC") il 9 luglio 2025 (la "Dichiarazione di registrazione").
More news about: Bitmine Immersion Technologies, Inc.
Jun 05, 2026, 14:38 ET A Bitmine Immersion Technologies anuncia proposta de oferta pública de ações preferenciais perpétuas da Série A
coordenadoras líderes conjuntas da oferta.A oferta está sendo realizada de acordo com uma declaração de registro prévia em vigor no Formulário S-3 (Arquivo nº 333-288579), arquivada na Comissão de Valores Mobiliários dos EUA (a "SEC") em 9 de julho de 2025 (a "Declaração de Registro"). A oferta
More news about: Bitmine Immersion Technologies, Inc.
Jun 05, 2026, 14:35 ET Bitmine Immersion Technologies anuncia una propuesta de emisión de acciones preferentes perpetuas de la Serie A
coordinadores conjuntos principales de la emisión.La emisión se ejecutará conforme una declaración de autorización permanente vigente en el formulario S-3 (Expediente n.° 333-288579), presentado ante la Comisión de Bolsa y Valores ("SEC", por sus siglas en inglés) el 9 de julio de 2025 (la "Declaración
More news about: Bitmine Immersion Technologies, Inc.